Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Guergueltcheva V
- Müller JS
- Dusl M
- Senderek J
- Oldfors A
- Lindbergh C
- Maxwell S
- Colomer J
- Mallebrera CJ
- Nascimento A
- Muelas N
- Kirschner J
- Nafissi S
- Kariminejad A
- Nilipour Y
- Bozorgmehr B
- Najmabadi H
- Rodolico C
- Sieb JP
- Schlotter B
- Schoser B
- Herrmann R
- Voit T
- Steinlein OK
- Najafi A
- Urtizberea A
- Soler DM
- Muntoni F
- Hanna MG
- Chaouch A
- Straub V
- Bushby K
- Palace J
- Beeson D
- Abicht A
- Lochmüller H
Grups d'Investigació
Abstract
Congenital myasthenic syndrome (CMS) is a clinically and genetically heterogeneous group of inherited disorders of the neuromuscular junction. A difficult to diagnose subgroup of CMS is characterised by proximal muscle weakness and fatigue while ocular and facial involvement is only minimal. DOK7 mutations have been identified as causing the disorder in about half of the cases. More recently, using classical positional cloning, we have identified mutations in a previously unrecognised CMS gene, GFPT1, in a series of DOK7-negative cases. However, detailed description of clinical features of GFPT1 patients has not been reported yet. Here we describe the clinical picture of 24 limb-girdle CMS (LG-CMS) patients and pathological findings of 18 of them, all carrying GFPT1 mutations. Additional patients with CMS, but without tubular aggregates, and patients with non-fatigable weakness with tubular aggregates were also screened. In most patients with GFPT1 mutations, onset of the disease occurs in the first decade of life with characteristic limb-girdle weakness and fatigue. A common feature was beneficial and sustained response to acetylcholinesterase inhibitor treatment. Most of the patients who had a muscle biopsy showed tubular aggregates in myofibers. Analysis of endplate morphology in one of the patients revealed unspecific abnormalities. Our study delineates the phenotype of CMS associated with GFPT1 mutations and expands the understanding of neuromuscular junction disorders. As tubular aggregates in context of a neuromuscular transmission defect appear to be highly indicative, we suggest calling this condition congenital myasthenic syndrome with tubular aggregates (CMS-TA).
Dades de la publicació
- ISSN/ISSNe:
- 0340-5354, 1432-1459
- Tipus:
- Article
- Pàgines:
- 838-850
- PubMed:
- 21975507
- Factor d'Impacte:
- 1,468 SCImago ℠
- Quartil:
- Q1 SCImago ℠
JOURNAL OF NEUROLOGY SPRINGER HEIDELBERG
Cites Rebudes en Web of Science: 61
Documents
- No hi ha documents
Filiacions
Keywords
- Congenital myasthenic syndromes, Dok-7, GFPT1, Limb-girdle myasthenia, Tubular aggregates
Projectes associats
INVESTIGACION EN RED DE LAS ENFERMEDADES NEUROLOGICAS
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
C03/06 . INSTITUTO DE SALUD CARLOS III . 2003
PROYECTO CAIBER
CAI08/01/0061 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2009
TRANSLATIONAL RESEARCH, EXPERIMENTAL MEDICINE AND THERAPEUTICS ON CHARCOT-MARIE-TOOTH. TREAT-CMT
Investigador Principal: JOSÉ MARÍA MILLÁN SALVADOR
TREAT-CMT . CIBER ENFERMEDADES RARAS; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
REGISTRO DEL SÍNDROME MIASTÉNICO DE LAMBERT-EATON.
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
BIO-AMI-2010-01 . 2014
ESTUDIO DE EXTENSIÓN ABIERTO DE LA SEGURIDAD, TOLERABILIDAD Y EFICACIA A LARGO PLAZO DE GSK2402968 EN SUJETOS CON DISTROFIA MUSCULAR DE DUCHENNE.
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
DMD114349 . 2012
ESTUDIO ABIERTO PARA PACIENTES CON DISTROFINOPATÍA POR MUTACIÓN SIN SENTIDO TRATADOS PREVIAMENTE CON ATALURENO (PTC124®).
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
PTC124-GD-019-DMD . 2012